Landmark Bio today announced it has been acquired by Artis BioSolutions ("Artis"), a newly launched company dedicated to streamlining the discovery, process development, and manufacturing of genetic medicines. The acquisition enables Landmark Bio to continue to deliver on its mission of translating groundbreaking research into life-changing therapies, while scaling its capabilities to accelerate development and manufacturing of advanced therapies. "Landmark Bio was bo

The International Hospital Federation (IHF) has opened Early Bird registration for the 48th World Hospital Congress. With the University Hospital of Geneva (HUG) and the Canton serving as host, this global event will take place from 10 to 13 November 2025 in Geneva, Switzerland. Registration is now open for the 48th IHF World Hospital Congress, taking place on 10–13 November at the International Conference Centre Geneva (CICG)

NSF, a leading global public health and safety organization, today announced the launch of NSF Certification Guideline 537: PFAS-Free Products for Nonfood Compounds and Food Equipment Materials (NSF 537). The new guideline leverages NSF’s extensive laboratory and testing capabilities to confirm that products are free of per- and polyfluoroalkyl substances (PFAS), a group of synthetic or man-made materials that resist degradation also known as “forever chemicals.” D

North American Partners in Anesthesia (NAPA) is pleased to announce it will begin providing anesthesia services on May 1, 2025, at Fayetteville Ambulatory Surgery Center (Fayetteville ASC). NAPA is the nation's largest single-specialty anesthesia management company. Fayetteville ASC is a leading provider of outpatient surgical care in North Carolina. This relationship aligns with the facility's commitment to excellence, innovation, and patient-centered care. The center sough

Pulse Biosciences, Inc. a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced plans to present at the upcoming 24th Annual Needham Virtual Health Care Conference. Pulse Biosciences’ Management is scheduled to present on Thursday, April 10, 2025, at 9:30 am ET. A live and recorded webcast of the presentation will be available on the “Events Calendar and Presentations” page

Voom Medical Devices, Inc., a leader in minimally invasive orthopedic solutions, is unveiling the new single-use sterile Revcon™ Screw System at the American College of Foot and Ankle Surgeons (ACFAS) annual meeting in Phoenix, AZ from March 26-29, 2025. The commercial launch of the system is slated for May 2025 and will include the highly anticipated debut of the MIBS CoPilot shift + targeting guide. Minimally invasive bunion surgery (MIBS) is rapidly becoming the procedure o

The St. Joe Company is excited to share that Florida State University (“FSU”) has announced plans to build a state-of-the-art acute care hospital in Panama City Beach under the “FSU Health” name to serve the residents of Bay and Walton counties. View the full release here: Florida State University News. “Access to quality healthcare is essential for the well-being of all residents in Northwest Florida,” said Jorge Gonzalez, Chairman, President and

Xcell Biosciences Australia PTY LTD (Xcellbio), an affiliate of Xcell Biosciences, Inc., a platform company focused on cell and gene therapy applications, and Royal Perth Hospital announced a collaboration aimed at developing an automated, clinical-scale manufacturing workflow for therapies based on tumor-infiltrating lymphocytes (TILs) using the AVATAR™ Foundry system. Ultimately, the goal is to empower Royal Perth Hospital physicians and clinical researchers to rapidly manufacture pot

InterSystems, a creative data technology provider managing over one billion healthcare records globally, and EMC Healthcare, a prominent healthcare provider in Indonesia, are excited to announce their strategic partnership aimed at revolutionizing patient care through the adoption of InterSystems' next-generation electronic health record (EHR) system, InterSystems IntelliCare™. This collaboration marks a significant step in enhancing healthcare delivery and operational efficiency ac

InMode Ltd. a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chief Executive Officer, and Yair Malca, Chief Financial Officer, will present at the 24th Annual Needham Virtual Healthcare Conference on April 8, 2025. The fireside chat, moderated by Michael Matson, Senior Equity Analyst, is scheduled for 2:15 pm Eastern Time on Tuesday, April 8, and a live webcast of the presentation can be accessed here. InMode will also hold one-on-one